199 related articles for article (PubMed ID: 11035137)
1. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy in women with systemic lupus erythematosus.
Sweeney DM; Manzi S; Janosky J; Selvaggi KJ; Ferri W; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
[TBL] [Abstract][Full Text] [Related]
3. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
4. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
5. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden.
Nived O; Bengtsson A; Jönsen A; Sturfelt G; Olsson H
Lupus; 2001; 10(7):500-4. PubMed ID: 11480849
[TBL] [Abstract][Full Text] [Related]
6. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
9. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
Tallbacka KR; Pettersson T; Pukkala E
Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
[TBL] [Abstract][Full Text] [Related]
11. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
[TBL] [Abstract][Full Text] [Related]
12. The association of malignancy with SLE: an analysis of 150 patients under long-term review.
Menon S; Snaith ML; Isenberg DA
Lupus; 1993 Jun; 2(3):177-81. PubMed ID: 8396490
[TBL] [Abstract][Full Text] [Related]
13. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
14. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
Chen YJ; Chang YT; Wang CB; Wu CY
Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
[TBL] [Abstract][Full Text] [Related]
15. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
[TBL] [Abstract][Full Text] [Related]
17. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
[TBL] [Abstract][Full Text] [Related]
18. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Bernatsky S; Ramsey-Goldman R; Joseph L; Boivin JF; Costenbader KH; Urowitz MB; Gladman DD; Fortin PR; Nived O; Petri MA; Jacobsen S; Manzi S; Ginzler EM; Isenberg D; Rahman A; Gordon C; Ruiz-Irastorza G; Yelin E; Bae SC; Wallace DJ; Peschken CA; Dooley MA; Edworthy SM; Aranow C; Kamen DL; Romero-Diaz J; Askanase A; Witte T; Barr SG; Criswell LA; Sturfelt GK; Blanco I; Feldman CH; Dreyer L; Patel NM; St Pierre Y; Clarke AE
Ann Rheum Dis; 2014 Jan; 73(1):138-42. PubMed ID: 23303389
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
